Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice

José Moltó, Asunción Blanco, Cristina Miranda, José Miranda, Jordi Puig, Marta Valle, Meritxell DelaVarga, Carmina R. Fumaz, Manuel José Barbanoj, Bonaventura Clotet

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)

Abstract

Aims: The objective of this study was to assess interindividual variability in plasma trough concentrations of non-nucleoside reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI) among HIV-infected adults in an outpatient routine clinical practice setting. Methods: The study included 117 patients who attended our clinic for routine outpatient blood tests and who were receiving antiretroviral therapy which included NNRTI or PI. Patients were not informed that drug concentrations were going to be assessed until blood sampling. The time of the last antiretroviral treatment intake and blood sampling were recorded. Drug concentrations were considered optimal if they were above the proposed minimum effective concentration. In addition, efavirenz, nevirapine and atazanavir concentrations were considered potentially toxic if they were higher than 4.0 mg l-1, 6.0 mg l-1, and 0.85 mg l-1, respectively. Results: Overall, interindividual variability in NNRTI and PI plasma concentrations was approximately 50%, and only 68.4% of the patients had drug concentrations within the proposed therapeutic range. Inappropriate adherence only explained 35% of subtherapeutic drug concentrations. Conclusion: Interindividual variability in trough concentrations of NNRTI and PI among HIV-infected adults is large in routine clinical practice, with drug concentrations being outside the therapeutic window in a significant proportion of patients. Therapeutic drug monitoring may be useful to guide antiretroviral therapy in clinical practice. © 2007 The Authors.
Original languageEnglish
Pages (from-to)715-721
JournalBritish Journal of Clinical Pharmacology
Volume63
Issue number6
DOIs
Publication statusPublished - 1 Jun 2007

Keywords

  • Antiretroviral agents
  • Clinical practice
  • Drug concentrations
  • HIV-infection
  • Interindividual variability

Fingerprint Dive into the research topics of 'Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice'. Together they form a unique fingerprint.

Cite this